We are live on ! Find out more
PG icon

Procter & Gamble

3,411 hedge funds and large institutions have $232B invested in Procter & Gamble in 2023 Q2 according to their latest regulatory filings, with 155 funds opening new positions, 1,407 increasing their positions, 1,449 reducing their positions, and 96 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more call options, than puts

Call options by funds: $2.53B | Put options by funds: $1.43B

61% more first-time investments, than exits

New positions opened: 155 | Existing positions closed: 96

1% more funds holding

Funds holding: 3,3773,411 (+34)

2% more capital invested

Capital invested by funds: $227B → $232B (+$4.96B)

3% less repeat investments, than reductions

Existing positions increased: 1,407 | Existing positions reduced: 1,449

1.41% less ownership

Funds ownership: 66.31%64.9% (-1.4%)

5% less funds holding in top 10

Funds holding in top 10: 283268 (-15)

Holders
3,411
Holders Change
+34
Holders Change %
+1.01%
% of All Funds
53.54%
Holding in Top 10
268
Holding in Top 10 Change
-15
Holding in Top 10 Change %
-5.3%
% of All Funds
4.21%
New
155
Increased
1,407
Reduced
1,449
Closed
96
Calls
$2.53B
Puts
$1.43B
Net Calls
+$1.11B
Net Calls Change
+$255M
Name Holding Trade Value Shares
Change
Change in
Stake
PAM
1051
Private Asset Management
California
$5.58M -$1.12M -7,441 -17%
ET
1052
Equitable Trust
Tennessee
$5.57M -$103K -686 -2%
GRQ
1053
Gardner Russo & Quinn
Pennsylvania
$5.57M -$22.9K -152 -0.4%
CA
1054
Claro Advisors
Massachusetts
$5.55M +$106K +704 +2%
JCM
1055
Jacobi Capital Management
Pennsylvania
$5.53M +$30.3K +201 +0.6%
WANY
1056
Wealthspire Advisors (New York)
New York
$5.53M +$42.5K +282 +0.8%
NHT
1057
New Hampshire Trust
New Hampshire
$5.5M -$16.6K -110 -0.3%
FTDI
1058
First Trust Direct Indexing
Massachusetts
$5.5M +$482K +3,199 +10%
CT
1059
Coastline Trust
Rhode Island
$5.49M -$24.1K -160 -0.4%
CHAM
1060
Clear Harbor Asset Management
Connecticut
$5.47M +$330K +2,191 +6%
SAM
1061
Smithbridge Asset Management
Pennsylvania
$5.47M -$7.84K -52 -0.1%
KFA
1062
Kapstone Financial Advisors
Ohio
$5.46M -$76.4K -507 -1%
SIA
1063
Soltis Investment Advisors
Utah
$5.46M +$268K +1,781 +5%
HWAM
1064
Hennion & Walsh Asset Management
New Jersey
$5.45M +$564K +3,739 +12%
FA
1065
Financial Avengers
California
$5.42M +$20.2K +134 +0.4%
VWA
1066
V Wealth Advisors
Kansas
$5.42M +$6.78K +45 +0.1%
BFA
1067
Benedict Financial Advisors
Georgia
$5.41M -$17.6K -117 -0.3%
NAM
1068
NTV Asset Management
West Virginia
$5.4M -$131K -872 -2%
AHB
1069
Abner Herrman & Brock
New Jersey
$5.4M +$444K +2,944 +9%
KFGK
1070
Keystone Financial Group (Kentucky)
Kentucky
$5.4M +$5.36M +35,560 New
SIM
1071
Stratos Investment Management
Ohio
$5.38M +$117K +774 +2%
ALAM
1072
Asahi Life Asset Management
Japan
$5.38M -$734K -4,873 -12%
SFS
1073
Sowell Financial Services
Arkansas
$5.38M +$1.65M +10,951 +45%
ADL
1074
Asset Dedication LLC
California
$5.35M +$216K +1,434 +4%
RDWM
1075
Red Door Wealth Management
Tennessee
$5.34M +$228K +1,516 +5%

PG Hedge Fund Activity: Q2 2023 in Review

3,411 of the 6,371 institutional investors tracked by Wall St. Rank reported a position in Procter & Gamble (PG) for Q2 2023, worth a combined $232B — up 2.2% from $227B a quarter earlier.

Buyers outnumbered sellers: 155 funds opened new PG positions and 96 closed out — a net gain of 59 holders — while 1,407 added to existing stakes and 1,449 trimmed.

The largest buyer was Fisher Asset Management, adding an estimated $646M. The largest seller was OFI Invest Asset Management, cutting an estimated $6.04B.

  • 3,411 institutional investors held Procter & Gamble (PG) as of Q2 2023, up from 3,377 in Q1 2023.
  • Funds reported $232B of Procter & Gamble stock for Q2 2023, up 2.2% quarter-over-quarter.
  • 155 funds opened new Procter & Gamble positions in Q2 2023 and 96 closed out, a net change of +59 holders.
  • The largest Procter & Gamble buyer in Q2 2023 was Fisher Asset Management, an estimated $646M added.
  • The largest Procter & Gamble seller in Q2 2023 was OFI Invest Asset Management, an estimated $6.04B sold.

Based on aggregated 13F filings for Q2 2023.